Leone D. Patterson - Sep 1, 2024 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
EVP, Chief Bus & Fin Officer
Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
Sep 1, 2024
Transactions value $
$0
Form type
4
Date filed
9/3/2024, 05:50 PM
Previous filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +360K $0.00 360K Sep 1, 2024 Common Stock 360K $11.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.